Table of Content
1 Introduction
1.1 Objective of the Study
1.2 Definition of the Market
1.3 Market Scope
1.3.1 Market Segment by Type, Application and Marketing Channel
1.3.2 Major Regions Covered (North America, Europe, Asia Pacific, Mid East & Africa)
1.4 Years Considered for the Study (2015-2028)
1.5 Currency Considered (U.S. Dollar)
1.6 Stakeholders
2 Key Findings of the Study
3 Market Dynamics
3.1 Driving Factors for this Market
3.2 Factors Challenging the Market
3.3 Opportunities of the Global Pomalidomide Market (Regions, Growing/Emerging Downstream Market Analysis)
3.4 Technological and Market Developments in the Pomalidomide Market
3.5 Industry News by Region
3.6 Regulatory Scenario by Region/Country
3.7 Market Investment Scenario Strategic Recommendations Analysis
4 Value Chain of the Pomalidomide Market
4.1 Value Chain Status
4.2 Upstream Raw Material Analysis
4.3 Midstream Major Company Analysis (by Manufacturing Base, by Product Type)
4.4 Distributors/Traders
4.5 Downstream Major Customer Analysis (by Region)
5 Global Pomalidomide Market-Segmentation by Type
5.1 1mg Tables
5.2 2mg Tables
5.3 4mg Tables
6 Global Pomalidomide Market-Segmentation by Application
6.1 Hospital
6.2 Drug Center
6.3 Clinic
6.4 Other
7 Global Pomalidomide Market-Segmentation by Marketing Channel
7.1 Traditional Marketing Channel (Offline)
7.2 Online Channel
8 Competitive Intelligence - Company Profiles
8.1 Celltrion
8.1.1 Celltrion Profile
8.1.2 Celltrion Sales, Growth Rate and Global Market Share from 2015-2020
8.1.3 Celltrion Product/Solution Launches and Enhancements Analysis
8.1.4 Celltrion Business Overview/Recent Development/Acquisitions
8.2 Fujifilm Kyowa Kirin Biologics
8.2.1 Fujifilm Kyowa Kirin Biologics Profile
8.2.2 Fujifilm Kyowa Kirin Biologics Sales, Growth Rate and Global Market Share from 2015-2020
8.2.3 Fujifilm Kyowa Kirin Biologics Product/Solution Launches and Enhancements Analysis
8.2.4 Fujifilm Kyowa Kirin Biologics Business Overview/Recent Development/Acquisitions
8.3 GlaxoSmithKline
8.3.1 GlaxoSmithKline Profile
8.3.2 GlaxoSmithKline Sales, Growth Rate and Global Market Share from 2015-2020
8.3.3 GlaxoSmithKline Product/Solution Launches and Enhancements Analysis
8.3.4 GlaxoSmithKline Business Overview/Recent Development/Acquisitions
8.4 Bionovis
8.4.1 Bionovis Profile
8.4.2 Bionovis Sales, Growth Rate and Global Market Share from 2015-2020
8.4.3 Bionovis Product/Solution Launches and Enhancements Analysis
8.4.4 Bionovis Business Overview/Recent Development/Acquisitions
8.5 Delenex Therapeutics
8.5.1 Delenex Therapeutics Profile
8.5.2 Delenex Therapeutics Sales, Growth Rate and Global Market Share from 2015-2020
8.5.3 Delenex Therapeutics Product/Solution Launches and Enhancements Analysis
8.5.4 Delenex Therapeutics Business Overview/Recent Development/Acquisitions
8.6 Tsumura
8.6.1 Tsumura Profile
8.6.2 Tsumura Sales, Growth Rate and Global Market Share from 2015-2020
8.6.3 Tsumura Product/Solution Launches and Enhancements Analysis
8.6.4 Tsumura Business Overview/Recent Development/Acquisitions
8.7 AryoGen Biopharma
8.7.1 AryoGen Biopharma Profile
8.7.2 AryoGen Biopharma Sales, Growth Rate and Global Market Share from 2015-2020
8.7.3 AryoGen Biopharma Product/Solution Launches and Enhancements Analysis
8.7.4 AryoGen Biopharma Business Overview/Recent Development/Acquisitions
8.8 Sandoz
8.8.1 Sandoz Profile
8.8.2 Sandoz Sales, Growth Rate and Global Market Share from 2015-2020
8.8.3 Sandoz Product/Solution Launches and Enhancements Analysis
8.8.4 Sandoz Business Overview/Recent Development/Acquisitions
8.9 Pfizer
8.9.1 Pfizer Profile
8.9.2 Pfizer Sales, Growth Rate and Global Market Share from 2015-2020
8.9.3 Pfizer Product/Solution Launches and Enhancements Analysis
8.9.4 Pfizer Business Overview/Recent Development/Acquisitions
8.10 MedImmune
8.10.1 MedImmune Profile
8.10.2 MedImmune Sales, Growth Rate and Global Market Share from 2015-2020
8.10.3 MedImmune Product/Solution Launches and Enhancements Analysis
8.10.4 MedImmune Business Overview/Recent Development/Acquisitions
9 Global Pomalidomide Market-Segmentation by Geography
10 North America
10.1 North America Pomalidomide Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
10.2 North America Pomalidomide Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
10.3 North America Pomalidomide Production Analysis from 2015-2020
10.4 North America Pomalidomide Consumption Analysis from 2015-2020
10.5 North America Pomalidomide Import and Export from 2015-2020
10.6 North America Pomalidomide Value, Production and Market Share by Type (2015-2020)
10.7 North America Pomalidomide Consumption, Value and Market Share by Application (2015-2020)
10.8 North America Pomalidomide by Country (United States, Canada)
10.8.1 North America Pomalidomide Sales by Country (2015-2020)
10.8.2 North America Pomalidomide Consumption Value by Country (2015-2020)
10.9 North America Pomalidomide Market PEST Analysis
11 Europe
11.1 Europe Pomalidomide Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
11.2 Europe Pomalidomide Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
11.3 Europe Pomalidomide Production Analysis from 2015-2020
11.4 Europe Pomalidomide Consumption Analysis from 2015-2020
11.5 Europe Pomalidomide Import and Export from 2015-2020
11.6 Europe Pomalidomide Value, Production and Market Share by Type (2015-2020)
11.7 Europe Pomalidomide Consumption, Value and Market Share by Application (2015-2020)
11.8 Europe Pomalidomide by Country (Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden, Poland, Belgium)
11.8.1 Europe Pomalidomide Sales by Country (2015-2020)
11.8.2 Europe Pomalidomide Consumption Value by Country (2015-2020)
11.9 Europe Pomalidomide Market PEST Analysis
12 Asia-Pacific
12.1 Asia-Pacific Pomalidomide Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
12.2 Asia-Pacific Pomalidomide Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
12.3 Asia-Pacific Pomalidomide Production Analysis from 2015-2020
12.4 Asia-Pacific Pomalidomide Consumption Analysis from 2015-2020
12.5 Asia-Pacific Pomalidomide Import and Export from 2015-2020
12.6 Asia-Pacific Pomalidomide Value, Production and Market Share by Type (2015-2020)
12.7 Asia-Pacific Pomalidomide Consumption, Value and Market Share by Application (2015-2020)
12.8 Asia-Pacific Pomalidomide by Country (China, Japan, South Korea, Australia, India, Taiwan, Indonesia, Thailand, Philippines, Malaysia)
12.8.1 Asia-Pacific Pomalidomide Sales by Country (2015-2020)
12.8.2 Asia-Pacific Pomalidomide Consumption Value by Country (2015-2020)
12.9 Asia-Pacific Pomalidomide Market PEST Analysis
13 Latin America
13.1 Latin America Pomalidomide Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
13.2 Latin America Pomalidomide Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
13.3 Latin America Pomalidomide Production Analysis from 2015-2020
13.4 Latin America Pomalidomide Consumption Analysis from 2015-2020
13.5 Latin America Pomalidomide Import and Export from 2015-2020
13.6 Latin America Pomalidomide Value, Production and Market Share by Type (2015-2020)
13.7 Latin America Pomalidomide Consumption, Value and Market Share by Application (2015-2020)
13.8 Latin America Pomalidomide by Country (Brazil, Mexico, Argentina, Columbia, Chile)
13.8.1 Latin America Pomalidomide Sales by Country (2015-2020)
13.8.2 Latin America Pomalidomide Consumption Value by Country (2015-2020)
13.9 Latin America Pomalidomide Market PEST Analysis
14 Middle East & Africa
14.1 Middle East & Africa Pomalidomide Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
14.2 Middle East & Africa Pomalidomide Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
14.3 Middle East & Africa Pomalidomide Production Analysis from 2015-2020
14.4 Middle East & Africa Pomalidomide Consumption Analysis from 2015-2020
14.5 Middle East & Africa Pomalidomide Import and Export from 2015-2020
14.6 Middle East & Africa Pomalidomide Value, Production and Market Share by Type (2015-2020)
14.7 Middle East & Africa Pomalidomide Consumption, Value and Market Share by Application (2015-2020)
14.8 Middle East & Africa Pomalidomide by Country (Saudi Arabia, UAE, Egypt, Nigeria, South Africa)
14.8.1 Middle East & Africa Pomalidomide Sales by Country (2015-2020)
14.8.2 Middle East & Africa Pomalidomide Consumption Value by Country (2015-2020)
14.9 Middle East & Africa Pomalidomide Market PEST Analysis
15 Future Forecast of the Global Pomalidomide Market from 2020-2028
15.1 Future Forecast of the Global Pomalidomide Market from 2020-2028 Segment by Region
15.2 Global Pomalidomide Production and Growth Rate Forecast by Type (2020-2028)
15.3 Global Pomalidomide Consumption and Growth Rate Forecast by Application (2020-2028)
16 Appendix
16.1 Methodology
16.2 Research Data Source
